Lv31
300 积分 2023-08-26 加入
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial
1小时前
求助中
Research on the progress of EGFR inhibitors in tumor inhibition and radio-sensitization
18天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
28天前
已关闭
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
28天前
已关闭
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
28天前
已完结
Real-world treatment patterns and clinical outcomes in EGFR-mutant locally advanced lung adenocarcinoma: A multi-center cohort study
1个月前
已完结
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer
1个月前
已完结
Thoracic Radiotherapy Improves the Survival in Patients With EGFR -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
1个月前
已完结
Osimertinib in Stage III EGFR -Mutated NSCLC — Game, Set, Match
1个月前
已完结
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
